Bloomberg Talks
Johnson & Johnson CFO Joseph Wolk Talks Earnings
Apr 16, 2024
Johnson & Johnson CFO Joseph Wolk discusses Q1 earnings, forecast, and product pipeline. Highlights include adjusted profit guidance, strong growth in pharmaceuticals & MedTech, new drug replacements, successful products like Trampia, recent acquisitions, and financing strategies for future growth.
08:36
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Johnson & Johnson saw 7.6% growth driven by pharmaceuticals, MedTech, with strategic acquisitions for future expansion.
- Transition to NetSuite optimizes financial operations, reduces costs, manual errors for business efficiency and profit maximization.
Deep dives
NetSuite by Oracle: Enhancing Financial Efficiency
Smart businesses are increasingly adopting NetSuite by Oracle, the leading cloud financial system. NetSuite integrates accounting, financial management, inventory, and HR functions into a unified platform, reducing IT costs, maintenance expenses, and manual errors. Over 37,000 companies have transitioned to NetSuite, benefiting from a flexible financing program. This shift towards NetSuite reflects a strategic move to optimize financial operations and maximize profit margins in the face of rising costs.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
